Squamous Cell Carcinoma
263
35
52
108
Key Insights
Highlights
Success Rate
77% trial completion
Published Results
54 trials with published results (21%)
Research Maturity
108 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
12.5%
33 terminated out of 263 trials
76.6%
-10.0% vs benchmark
4%
11 trials in Phase 3/4
50%
54 of 108 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 108 completed trials
Clinical Trials (263)
Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Toripalimab With Chemotherapy for Sinus Cancer
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Impact of Dysport on PMFF Donor Scar
Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
PDT For Induction Therapy For Head And Neck Cancer